Save the date - Essity’s Capital Markets Day, May 7, 2026

Essity has scheduled a Capital Markets Day on May 7, 2026 in Gothenburg where CEO Ulrika Kolsrud and the Executive Management Team will present the company’s strategy to drive profitable volume growth and accelerate delivery of its financial targets; presentations will be available virtually and include afternoon visits to local R&D and production sites. The company, listed on Nasdaq Stockholm, reported 2024 net sales of ~SEK 146bn (EUR 13bn) and 36,000 employees; the event is targeted at institutional investors, analysts and the media and is primarily an investor-relations strategic update rather than a new financial disclosure.

Analysis

Market structure: Essity (ESSITY.ST) is the direct beneficiary—a well-telegraphed Capital Markets Day focused on “profitable volume growth” and R&D/production tours signals management pushing for share gains and premiumization in personal hygiene; suppliers (SCA.ST, pulp producers) and packaging vendors stand to gain 5–15% revenue tailwinds if capex/volume guidance is aggressive. Losers include low‑end private‑label tissue makers and regional EM rivals without scale, who could lose pricing power and shelf space. Cross-asset: expect a modest tightening in Essity credit spreads if guidance is credible (10–30bps), a 1–2% SEK appreciation on positive investor flows, and a 20–40% intraday lift in implied equity options volatility around May 7.

Risk assessment: Tail risks include a 20–40% spike in pulp/energy costs, product-regulatory recalls, or a credibility gap if targets lack concrete KPIs; any of these could wipe out a 10–25% stock move. Time horizons: immediate (days) = volatility around CMD; short-term (weeks–months) = re-rating if guidance is convincing; long-term (quarters–years) = realized margin improvement from premiumization or FCF drag from elevated capex. Hidden dependencies: retail promotional intensity, public healthcare procurement cycles for TENA, and FX (SEK/EUR) can swing EBIT by hundreds of basis points. Key catalysts: May 7 CMD, subsequent Q2 results, pulp price reports over next 3–6 months.

Trade implications: Direct play—establish a 2–3% long position in ESSITY.ST into CMD with a 3–6 month target +15% and stop-loss at −8%; alternatively buy a June 2026 1–3% notional call spread to cap downside and capture upside. Pair trade—long ESSITY.ST vs short KMB (~1–2% notional) to express European premiumization vs US commodity exposure. Add 1–2% exposure to SCA.ST to play upstream benefit; reduce cash-weighted exposure to smaller EM tissue names.

Contrarian angles: Consensus may underweight the downside of aggressive capex—management could sacrifice short-term margins to hit volume targets, pressuring FCF and dividends, a scenario markets underprice. Conversely, markets may underappreciate margin upside from product mix — a credible KPI package (gross margin +100–200bp target) could trigger a 10–25% re-rating. Watch for historical parallels (KMB turnarounds after portfolio focus) and monitor a >100bp QoQ gross-margin delta as a trigger to scale positions.

Key Decisions for Investors

• Initiate a 2–3% long position in ESSITY.ST within 10 trading days before May 7 CMD; set a 3–6 month price target of +15% and a hard stop-loss at −8% to limit downside if guidance disappoints.
• Buy a capped upside options structure: June 2026 call spread on ESSITY.ST sized to 1–2% portfolio risk (buy ATM calls, sell higher strike ~10–15% out) to capture CMD-driven re-rating while limiting premium spend.
• Establish a 1–2% long position in SCA.ST (Swedish pulp/forest exposure) as a supplier play; take profit if pulp price futures rise >30% (realized margin pressure for Essity) or hold as tactical hedge for 6–12 months.
• Implement a pair trade: long ESSITY.ST (2%) vs short KMB (1–2%) to express expected European premiumization/margin expansion vs US commodity pressure; rebalance after CMD and close within 3–6 months or if spread contracts >50bps.
• If CMD fails to provide KPIs (explicit targets for gross margin +100–200bp and FCF runway), reduce Essity exposure to <0.5% within 2 weeks and consider short protection (buy 3–6 month puts sized to 1% portfolio) to hedge tail risk.